Farallon Capital Management Upped By $12.98 Million Its Gw Pharmaceuticals Plc (GWPH) Position; Mallinckrodt Public Limited Company (MNK) Shorts Lowered By 9.74%

August 28, 2017 - By Peter Erickson

Farallon Capital Management Llc increased Gw Pharmaceuticals Plc (GWPH) stake by 377.19% reported in 2016Q4 SEC filing. Farallon Capital Management Llc acquired 116,928 shares as Gw Pharmaceuticals Plc (GWPH)’s stock declined 18.00%. The Farallon Capital Management Llc holds 147,928 shares with $16.53M value, up from 31,000 last quarter. Gw Pharmaceuticals Plc now has $2.52B valuation. The stock declined 1.61% or $1.63 reaching $99.43 on the news. About 113,739 shares traded. GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) has risen 31.90% since August 28, 2016 and is uptrending. It has outperformed by 15.20% the S&P500.

Mallinckrodt Public Limited Company (NYSE:MNK) had a decrease of 9.74% in short interest. MNK’s SI was 17.71M shares in August as released by FINRA. Its down 9.74% from 19.62 million shares previously. With 3.67M avg volume, 5 days are for Mallinckrodt Public Limited Company (NYSE:MNK)’s short sellers to cover MNK’s short positions. The SI to Mallinckrodt Public Limited Company’s float is 19.42%. About 959,217 shares traded. Mallinckrodt PLC (NYSE:MNK) has declined 30.39% since August 28, 2016 and is downtrending. It has underperformed by 47.09% the S&P500.

Farallon Capital Management Llc decreased Alere Inc (NYSE:ALR) stake by 70,000 shares to 2.25 million valued at $87.49M in 2016Q4. It also reduced Spdr S&P 500 Etf Tr (Put) (SPY) stake by 2.87M shares and now owns 1.80 million shares. Hudson Pac Pptys Inc (NYSE:HPP) was reduced too.

Among 11 analysts covering GW Pharmaceuticals (NASDAQ:GWPH), 9 have Buy rating, 1 Sell and 1 Hold. Therefore 82% are positive. GW Pharmaceuticals had 16 analyst reports since August 13, 2015 according to SRatingsIntel. Cantor Fitzgerald maintained GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) on Monday, September 26 with “Buy” rating. The firm earned “Buy” rating on Friday, June 3 by Cantor Fitzgerald. The firm has “Buy” rating given on Tuesday, August 8 by Cantor Fitzgerald. The firm has “Buy” rating by TH Capital given on Monday, November 30. The firm has “Buy” rating given on Friday, October 7 by Goldman Sachs. Piper Jaffray maintained GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) rating on Thursday, August 3. Piper Jaffray has “Buy” rating and $14700 target. The stock has “Buy” rating by Roth Capital on Monday, November 30. Roth Capital maintained it with “Buy” rating and $160 target in Monday, March 14 report. The company was initiated on Monday, June 27 by Janney Capital. The stock of GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) has “Hold” rating given on Friday, August 26 by Numis Securities.

Since March 7, 2017, it had 10 buys, and 0 insider sales for $656,712 activity. Another trade for 290 shares valued at $14,602 was bought by Hicks Michael-Bryant. On Friday, June 2 Lannum Coleman N III bought $57,904 worth of Mallinckrodt PLC (NYSE:MNK) or 1,350 shares. 5,000 shares valued at $206,320 were bought by LLOYD RONALD K. on Friday, June 9. O’Neill Hugh M. had bought 1,000 shares worth $40,237 on Thursday, June 8. Romano Steven J. bought $39,881 worth of Mallinckrodt PLC (NYSE:MNK) on Friday, June 9. Trudeau Mark bought $40,174 worth of stock or 1,000 shares. Harbaugh Matthew K bought $29,514 worth of Mallinckrodt PLC (NYSE:MNK) on Friday, March 10.

Among 20 analysts covering Mallinckrodt (NYSE:MNK), 17 have Buy rating, 0 Sell and 3 Hold. Therefore 85% are positive. Mallinckrodt had 62 analyst reports since August 5, 2015 according to SRatingsIntel. On Wednesday, October 14 the stock rating was initiated by Northland Capital with “Outperform”. Mizuho maintained the stock with “Neutral” rating in Wednesday, December 9 report. Jefferies maintained the stock with “Buy” rating in Monday, April 24 report. As per Wednesday, December 7, the company rating was reinitiated by Oppenheimer. Mizuho maintained Mallinckrodt PLC (NYSE:MNK) on Friday, February 3 with “Buy” rating. Mizuho maintained the stock with “Buy” rating in Thursday, July 21 report. The stock of Mallinckrodt PLC (NYSE:MNK) earned “Buy” rating by Jefferies on Friday, August 25. On Thursday, September 29 the stock rating was maintained by Mizuho with “Buy”. Jefferies maintained the stock with “Buy” rating in Friday, May 26 report. The stock of Mallinckrodt PLC (NYSE:MNK) earned “Buy” rating by Piper Jaffray on Friday, July 14.

Mallinckrodt public limited company develops, makes, markets and distributes branded and generic specialty pharmaceutical products and therapies. The company has market cap of $3.75 billion. The Firm focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs. It currently has negative earnings. The Company’s divisions include Specialty Brands and Specialty Generics.

Investors sentiment decreased to 0.72 in 2016 Q4. Its down 0.30, from 1.02 in 2016Q3. It worsened, as 62 investors sold Mallinckrodt PLC shares while 130 reduced holdings. 70 funds opened positions while 127 raised stakes. 92.55 million shares or 0.45% more from 92.14 million shares in 2016Q3 were reported. Princeton Alpha Mgmt L P has 19,707 shares for 0.2% of their portfolio. Comerica National Bank & Trust owns 25,962 shares for 0.01% of their portfolio. American Century has 7,967 shares. Deerfield Mgmt reported 407,000 shares or 0.83% of all its holdings. Mufg Americas Hldgs Corp reported 103 shares. Benjamin F Edwards Com reported 321 shares. Point72 Asset L P holds 0.04% or 120,900 shares in its portfolio. Rockefeller Fincl Incorporated accumulated 7,767 shares. Gruss Inc holds 14,000 shares or 0.76% of its portfolio. Arrowstreet Limited Partnership owns 64,500 shares. Prudential Plc owns 216,998 shares. Principal has invested 0.01% of its portfolio in Mallinckrodt PLC (NYSE:MNK). Meiji Yasuda Asset Mgmt Com holds 0.04% in Mallinckrodt PLC (NYSE:MNK) or 6,360 shares. Jacobs Levy Equity accumulated 215,290 shares or 0.21% of the stock. Moreover, Estabrook Cap Mngmt has 0% invested in Mallinckrodt PLC (NYSE:MNK).